Renyi-Vamos F - Search Results

1

Mechanisms of vascularization in murine models of primary and metastatic tumor growth.

Bugyik E, Renyi-Vamos F, Szabo V, Dezso K, Ecker N, Rokusz A, Nagy P, Dome B, Paku S. Bugyik E, et al. Chin J Cancer. 2016 Feb 12;35:19. doi: 10.1186/s40880-016-0083-5. Chin J Cancer. 2016. PMID: 26873579 Free PMC article. Review.

2

The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization.

Paku S, Laszlo V, Dezso K, Nagy P, Hoda MA, Klepetko W, Renyi-Vamos F, Timar J, Reynolds AR, Dome B. Paku S, et al. J Pathol. 2017 Mar;241(4):441-447. doi: 10.1002/path.4855. Epub 2017 Jan 27. J Pathol. 2017. PMID: 28026875

3

Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.

Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Renyi-Vamos F, et al. Clin Cancer Res. 2005 Oct 15;11(20):7344-53. doi: 10.1158/1078-0432.CCR-05-1077. Clin Cancer Res. 2005. PMID: 16243806

4

Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.

Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, Klepetko W, Lang G, Dome P, Bogos K, Tovari J. Dome B, et al. Crit Rev Oncol Hematol. 2009 Feb;69(2):108-24. doi: 10.1016/j.critrevonc.2008.06.009. Epub 2008 Sep 3. Crit Rev Oncol Hematol. 2009. PMID: 18768327 Review.

5

Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.

Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B. Berta J, et al. J Thorac Oncol. 2010 Aug;5(8):1120-9. doi: 10.1097/JTO.0b013e3181e2c1ff. J Thorac Oncol. 2010. PMID: 20581707 Free article.

6

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

Bridgeman VL, Vermeulen PB, Foo S, Bilecz A, Daley F, Kostaras E, Nathan MR, Wan E, Frentzas S, Schweiger T, Hegedus B, Hoetzenecker K, Renyi-Vamos F, Kuczynski EA, Vasudev NS, Larkin J, Gore M, Dvorak HF, Paku S, Kerbel RS, Dome B, Reynolds AR. Bridgeman VL, et al. J Pathol. 2017 Feb;241(3):362-374. doi: 10.1002/path.4845. Epub 2016 Dec 29. J Pathol. 2017. PMID: 27859259 Free PMC article.

7

The landscape of small cell lung cancer metastases: Organ specificity and timing.

Megyesfalvi Z, Tallosy B, Pipek O, Fillinger J, Lang C, Klikovits T, Schwendenwein A, Hoda MA, Renyi-Vamos F, Laszlo V, Rezeli M, Moldvay J, Dome B. Megyesfalvi Z, et al. Thorac Cancer. 2021 Mar;12(6):914-923. doi: 10.1111/1759-7714.13854. Epub 2021 Feb 3. Thorac Cancer. 2021. PMID: 33533174 Free PMC article.

8

High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.

Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. Bogos K, et al. Clin Cancer Res. 2009 Mar 1;15(5):1741-6. doi: 10.1158/1078-0432.CCR-08-1372. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240177

9

Apelin promotes lymphangiogenesis and lymph node metastasis.

Berta J, Hoda MA, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, Dome B. Berta J, et al. Oncotarget. 2014 Jun 30;5(12):4426-37. doi: 10.18632/oncotarget.2032. Oncotarget. 2014. PMID: 24962866 Free PMC article.

10

Molecular profiles of small cell lung cancer subtypes: therapeutic implications.

Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, Ferencz B, Paku S, Lantos A, Fillinger J, Rezeli M, Marko-Varga G, Bogos K, Galffy G, Renyi-Vamos F, Hoda MA, Klepetko W, Hoetzenecker K, Laszlo V, Dome B. Schwendenwein A, et al. Mol Ther Oncolytics. 2021 Feb 6;20:470-483. doi: 10.1016/j.omto.2021.02.004. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33718595 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page